drug
ST316
Phase 2updated 6mo agoby Sapience Therapeutics Inc
Phase 2community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying ST316
News(1)
- Once undruggable, the Wnt/B-catenin pathway shows increasing promiseEarly-stage clinical data from our company and others point to the Wnt/β-catenin pathway as a new avenue for targeting multiple cancer types.biospace · 18d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that